| A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers (NCT07658482) | Zai Lab (Shanghai) Co., Ltd. | 2026-09-03 |
| Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors (NCT07374848) | Zai Lab (Shanghai) Co., Ltd. | 2026-03-02 |
| A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease (NCT07211776) | Zai Lab (Shanghai) Co., Ltd. | 2025-12-05 |
| A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis (NCT07235384) | Zai Lab (Shanghai) Co., Ltd. | 2025-12-01 |
| A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) (NCT07218146) | Zai Lab (Shanghai) Co., Ltd. | 2025-11-30 |
| A Study of ZL-1310 in Participants With Selected Solid Tumors (NCT06885281) | Zai Lab (Shanghai) Co., Ltd. | 2025-05-12 |
| A Study of ZL-1310 in Subjects With Small Cell Lung Cancer (NCT06179069) | Zai Lab (Shanghai) Co., Ltd. | 2024-01-23 |
| To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies (NCT05866354) | Zai Lab (Shanghai) Co., Ltd. | 2023-06-16 |
| The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors (NCT05263986) | Zai Lab (Shanghai) Co., Ltd. | 2022-05-30 |
| A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib (NCT04633122) | Zai Lab (Shanghai) Co., Ltd. | 2020-11-25 |
| A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma (NCT04653038) | Zai Lab (Shanghai) Co., Ltd. | 2020-10-29 |
| A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC (NCT04398108) | Zai Lab (Shanghai) Co., Ltd. | 2020-08-25 |
| A Study of Niraparib in Patients With Relapsed Ovarian Cancer (NCT04392102) | Zai Lab (Shanghai) Co., Ltd. | 2020-08-04 |
| A Trial of ZL-1201 in Subjects With Advanced Cancer (NCT04257617) | Zai Lab (Shanghai) Co., Ltd. | 2020-05-11 |
| A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT04282980) | Zai Lab (Shanghai) Co., Ltd. | 2020-04-23 |
| MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients (NCT04212221) | Zai Lab (Shanghai) Co., Ltd. | 2020-04-20 |
| A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment (NCT04178460) | Zai Lab (Shanghai) Co., Ltd. | 2020-02-03 |
| A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC (NCT04262804) | Zai Lab (Shanghai) Co., Ltd. | 2020-01-13 |
| A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer (NCT03516084) | Zai Lab (Shanghai) Co., Ltd. | 2018-08-20 |